Use this resource hub to reach official guidance from ICH, EMA, SFDA, FDA and WHO when planning pharmaceutical development, CMC, clinical research, GMP/quality or regulated healthcare work. These links are intended to help teams start from the authority source rather than relying on copied or outdated summaries.
International harmonisation guidance across Quality (Q), Safety (S), Efficacy (E) and Multidisciplinary (M) topics, including many core standards used in pharmaceutical development, CMC and clinical research.
European Medicines Agency scientific and procedural guidance for development, quality, clinical evidence, submissions, variations and lifecycle activities in the European regulatory system.
Saudi Food & Drug Authority requirements and guidance for regulated products, establishments and clinical trials in the Kingdom of Saudi Arabia.
U.S. Food and Drug Administration guidance covering drugs, biologics, medical devices, manufacturing, clinical development and regulatory submissions.
World Health Organization norms, technical guidance and quality/GMP resources used across global health and pharmaceutical manufacturing contexts.
Regulatory guidance changes over time, and the official authority publication is the controlling source. The correct document also depends on product type, development stage, intended market and specific regulatory question. For project-specific interpretation, document mapping or submission planning, contact our Regulatory Affairs team.
Diagnostics